PAROLA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 12.403
AS - Asia 11.283
EU - Europa 8.629
SA - Sud America 680
AF - Africa 314
OC - Oceania 218
Continente sconosciuto - Info sul continente non disponibili 20
Totale 33.547
Nazione #
US - Stati Uniti d'America 11.685
CN - Cina 7.536
IT - Italia 1.610
DE - Germania 1.145
IE - Irlanda 950
SE - Svezia 939
SG - Singapore 738
FR - Francia 702
FI - Finlandia 568
KR - Corea 550
GB - Regno Unito 541
UA - Ucraina 501
JP - Giappone 479
MX - Messico 455
HK - Hong Kong 368
IN - India 299
ES - Italia 286
PL - Polonia 283
VN - Vietnam 263
BR - Brasile 260
ID - Indonesia 222
CA - Canada 217
AU - Australia 206
TR - Turchia 202
TW - Taiwan 200
EG - Egitto 185
AT - Austria 147
NL - Olanda 136
DK - Danimarca 132
RO - Romania 128
PE - Perù 117
RU - Federazione Russa 102
CL - Cile 94
IR - Iran 89
CO - Colombia 83
CH - Svizzera 76
BE - Belgio 75
PK - Pakistan 69
EC - Ecuador 59
GR - Grecia 58
BY - Bielorussia 57
PT - Portogallo 53
TH - Thailandia 53
AR - Argentina 46
SN - Senegal 41
IL - Israele 35
CZ - Repubblica Ceca 32
SA - Arabia Saudita 28
EU - Europa 20
HR - Croazia 20
MY - Malesia 20
RS - Serbia 19
MA - Marocco 17
KG - Kirghizistan 16
ZA - Sudafrica 16
IQ - Iraq 12
HU - Ungheria 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
PA - Panama 11
PS - Palestinian Territory 11
VE - Venezuela 11
DZ - Algeria 10
GE - Georgia 10
JO - Giordania 10
LB - Libano 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
KZ - Kazakistan 9
SK - Slovacchia (Repubblica Slovacca) 9
BO - Bolivia 8
LT - Lituania 8
NG - Nigeria 8
NI - Nicaragua 8
MO - Macao, regione amministrativa speciale della Cina 7
NP - Nepal 7
BA - Bosnia-Erzegovina 6
GT - Guatemala 6
BD - Bangladesh 5
PR - Porto Rico 5
SI - Slovenia 5
SY - Repubblica araba siriana 5
TN - Tunisia 5
CR - Costa Rica 4
CY - Cipro 4
KE - Kenya 4
MN - Mongolia 4
MU - Mauritius 4
PH - Filippine 4
ZM - Zambia 4
AL - Albania 3
CU - Cuba 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HN - Honduras 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LY - Libia 3
NE - Niger 3
AM - Armenia 2
Totale 33.522
Città #
Beijing 1.827
Chandler 1.300
Dublin 939
Ann Arbor 812
Shanghai 679
Fairfield 649
Houston 648
Singapore 556
Ashburn 456
Guangzhou 436
Jacksonville 394
Torino 364
Redwood City 360
Seattle 349
Villeurbanne 345
Wilmington 345
Woodbridge 343
Princeton 288
Nanjing 285
Medford 278
Columbus 263
Dearborn 252
Nyköping 240
Warsaw 220
Cambridge 209
Hangzhou 201
Chengdu 180
Pisa 173
Wuhan 171
Boston 167
Milan 154
Zhengzhou 152
Hefei 146
Düsseldorf 145
Xian 131
Boardman 125
Taipei 125
Dong Ket 121
Changsha 110
Jakarta 107
Brisbane 106
Jinan 104
Tokyo 104
Vienna 104
New York 103
Shenyang 99
Chongqing 93
Central 82
Fremont 78
Santiago 74
Lima 73
Guiyang 72
Tianjin 71
Barcelona 68
Turin 66
Santa Clara 64
London 61
Nanning 57
San Diego 57
Fuzhou 54
Rome 54
Los Angeles 53
Washington 52
Florence 51
Changchun 50
Cairo 49
Lanzhou 48
Toronto 48
Kunming 46
Seoul 44
Norwalk 42
Brussels 41
Central District 39
Harbin 39
Hong Kong 39
Munich 39
Nanchang 39
Xiamen 39
Mexico City 38
Ottawa 38
Madrid 35
Xi'an 35
Hebei 34
Guadalajara 33
Istanbul 33
Verona 33
Falls Church 32
Helsinki 32
Bogotá 31
Frankfurt am Main 31
Guayaquil 31
Phoenix 31
Hanoi 30
New Delhi 29
Silver Spring 29
Pittsburgh 28
São Paulo 28
Athens 26
Padova 26
Sydney 26
Totale 18.136
Nome #
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues 8.241
Liver fibrosis: a dynamic and potentially reversible process. 1.097
Pathophysiology of Organ and Tissue Fibrosis 771
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 657
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 614
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 593
Cellular And Molecular Mechanisms In Liver Fibrogenesis. 561
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH). 532
Hypoxia, hypoxia inducible factors and fibrogenesis in chronic liver diseases 518
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 491
Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases 434
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 351
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. 280
Adipokines and Redox Signaling: Impact on Fatty Liver Disease 258
Angiogenesis and liver fibrogenesis 247
Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine 241
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells 240
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data 228
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. 201
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice 197
Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression. 197
SENP1 activity sustains cancer stem cell in hypoxic HCC 196
Therapeutic pro-fibrogenic signaling pathways in fibroblasts 190
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 189
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 186
Liver fibrogenesis: un update on established and emerging basic concepts 183
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 182
Of FACT complex and oxidative stress response: a KEAP1/NRF2-dependent novel mechanism sustaining hepatocellular carcinoma progression 181
Hepatic myofibroblasts: a heterogenous population of multifunctional cells in liver fibrogenesis 174
Hypoxia-inducible factor 2alpha drives the progression of experimental non-alcoholic fatty liver disease by stimulating hepatocyte production of histidine rich glycoprotein 172
Curcumin limits the fibrogenic evolution of experimental steatohepatitis 172
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells 171
Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells. 160
Angiogenesis and Fibrogenesis in Chronic Liver Diseases 155
The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis 147
Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis 144
Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence. 142
Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components 140
VEGF ed Angiopoietina-1: fattori ipossia- e leptina-dipendenti capaci di indurre migrazione e chemiotasssi in cellule stellate epatiche umane 137
Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis 131
4-Idrossinonenale come stimolo pro-fibrogenico selettivo per le cellule stellate umane attivate 130
Hepatic progenitor cells express SerpinB3 129
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 129
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. 128
Dynamics of sodium retention in preascitic cirrhotic rats assessed through parathyroid hormone injection. 128
Dose-dependecy of clonidine's effects in ascitic cirrhotic rats: Comparison with α1-adrenergic agonist midodrine. 126
Pathogenesis of Solute-Free Water Retention in Experimental Ascitic Cirrhosis: Is Vasopressin the Only Culprit? 126
In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future? 125
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells 122
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 119
[Changes in adenosinetriphosphatase activity in rat liver after CC14 poisoning] 111
4-Hydroxy-2,3-nonenal as a signal for cell function and differentiation. 109
Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block 107
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways 107
NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signaling. 107
Effect of 4-hydroxynonenal on c-myc expression. 105
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells 105
4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. 104
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 101
SERPIN-B3 can contribute to fibrogenic progression of chronic liver diseases towards cirrhosis and HCC development 98
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 97
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis 97
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases 96
Subcellular calmodulin distribution in rat liver after CCl4 poisoning. 94
In vivo and in vitro evidence concerning the role of lipid peroxidation in the mechanism of hepatocyte death due to carbon tetrachloride. 92
Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by alpha-tocopherol or gadolinium chloride. 92
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 91
In experimental ascitic cirrhosis reduction of adrenergic function by means of α2A adrenergic receptor agonists has considerable aquaretic effects 91
Hypoxia – induced migration of human hepatic stellate cellsrequires an early and redox sensitive activation of c-Jun N-terminal kinase 90
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. 90
Common signalling events regulate migration and chemotaxis of hepatic stellate cells and bone marrow – derived mesenchymal stem cells 89
Chemotaxis in Profibrogenic Human Hepatic Stellate Cells Requires Redox – Dependent Activation of c-Jun N-Terminal Kinase Isoforms 1 and 2 89
Oncostatin M, overexpressed in hepatocellular carcinoma, up-regulates SERPIN-B3 expression in hepatic cancer cells 88
Considerable aquaretic effects in experimental ascitic cirrhosis achieved through blunting of adrenergic function with α2A adrenergic receptor agonists 88
Bcl-2 overexpression in human activated hepatic stellate cells: a survival and pro-fibrogenic mechanism 87
Local renin–angiotensin system in the kidney of ascitic cirrhosis: An innocent bystander or a major protagonist? 87
SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers 87
Common signalling and redox sensitive events regulate migration and chemotaxis of bone marrow – derived mesenchymal stem cells and hepatic stellate cells. 86
Oncostatin M stimulates directional migration of human hepatic pro-fibrogenic cells. 86
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress 85
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 85
Effect of Epomediol on the ATPase and adenylate cyclase activities in plasmamembranes isolated from rat liver. 84
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2 alpha 84
Hypoxia - induced migration of human hepatic stellate cells requires an early and redox sensitive activation of c-jun n-terminal kinase 83
Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells 83
Beta-catenin triggers nuclear factor kB - dependent up-regulation of hepatocyte inducible nitric oxide synthase 83
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 83
Calcium-dependent diuretic system in preascitic liver cirrhosis. 81
4-Hydroxy-2,3-alkenals as signal molecules modulating proliferative and adaptative cell responses. 81
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 80
Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells 80
Hepatic myofibroblasts: origin and role in liver fibrogenesis 80
Hypoxia drives epithelial mesenchymal transition in neoplastic cells of the gastro-intestinal tract: a beta-catenin and snail–mediated event favouring migration and/or invasiveness 79
4-Hydroxynonenal elicits in human hepatic stellate cells a c-jun/JNK2/AP-1 signalling pathway preceeded by early generation of nuclear adducts. 79
Serpinb3 is overexpressed in the liver in presence of iron overload 79
Bone Marrow – Derived Mesenchymal Stem Cells Engraft Chronically Injured Liver and Differentiate Into Pro-fibrogenic Myofibroblast-Like Cells: the Role of PDGF-BB 78
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 78
Curcumin inhibits the fibrogenic progression of murine steatohepatitis 77
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 77
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 77
Totale 25.830
Categoria #
all - tutte 81.237
article - articoli 0
book - libri 0
conference - conferenze 22.419
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.039 0 0 0 0 271 567 462 335 453 422 305 224
2020/20214.942 380 279 356 334 472 399 436 288 542 473 388 595
2021/20225.186 441 379 414 486 381 309 346 369 373 273 675 740
2022/20235.344 526 362 167 515 467 1.064 440 409 518 215 300 361
2023/20245.125 503 506 383 370 575 522 298 540 136 362 400 530
2024/20252.197 348 531 536 682 100 0 0 0 0 0 0 0
Totale 34.611